now browsing by category


Clay Siegall’s Struggle to Destroy Cancer

In the year 1998, Mr. Clay Siegall worked really hard in creating the Seattle Genetics. After several years he became a resident of this Seattle Genetics. This Seattle Genetics is basically an institute where people do research on the subject of cancer. Mr. Clay Siegall has taken different roles in this Institute. These roles include CEO, President and Chairman of the board of Seattle Genetics as well. He has been very passionate about his work and this Institute. He has put a lot of effort into finding the cure for cancer. Most of his operations are focused on the subject of cancer therapy. This is basically a process that is meant for patients going through cancer. This makes the whole process somewhat comfortable for such patients.


Dr. Clay Siegall has a vast experience in this field. He has been working as a scientist for many years now. He has completed his bachelor’s degree in zoology and completed his Ph.D. in genetics. In addition to all that, he has been working as a researcher as well. His main area of focus has been the drugs used in cancer therapy process. He loves helping other people, and this resulted in working day and night, researching about best drugs that people could use who are going through cancer therapy. Thanks to Dr. Clay Siegall’s struggles, the company Seattle Genetics has been able to develop different treatments for people.


In addition to working as a researcher, Dr. Clay Siegall is considered a philanthropist as well. He has been able to raise a lot of money through different charity events. He has raised over a million dollars for charity. He has also been able to publish different articles. The idea behind publishing articles is that he wants to keep other doctors and scientists updated about the advancement in his research. He believes that by sharing his knowledge, other people will get inspired to work on this subject as well and they all will be able to develop a working cure for cancer.


It is Dr. Clay Siegall’s passion to help everyone as much as he can. Seattle Genetics has given him a platform to do so on a larger scale.

Greg Secker’s Brilliant Career as a Speaker

Originally from Norfolk, England, Greg Secker is an entrepreneur and financial trader. He attended the University of Nottingham, where he earned a degree in Agriculture and Food Sciences. However, instead of pursuing agronomy, he embarked on a career in financial services. As an engineer for Thomas Cook Financial Services, he developed electronic systems for foreign exchange trading, creating the first online Forex trading platform called Virtual Trading Desk, which was a tremendous success.


Still only 25 years old, Secker left Thomas Cook Financial for Mellon Financial Corporation in the United States, where he was Vice President, and became a full-fledged trader himself. As he honed his skills as a day-trader, he became increasingly confident of his ability to teach others to trade on the foreign and stock exchanges. In 2003, he became an independent home-based trader and founded a company to mentor novice traders called “Knowledge to Action.”


By 2008, Secker had become a sought-after public speaker, hosting seminars in such far-flung places as Ghana and New Zealand. Through his Knowledge to Action organization, he endeavored to teach others the techniques he had acquired during his time at Mellon and which he used on a daily basis. Over 100,000 people have participated in his trading seminars. As a result of his popularity as a speaker and trainer, he is frequently interviewed on channels such as CNBC and Bloomberg and quoted in financial publications as an expert.


The success of his training courses has also led him to be recognized as a power motivational speaker. In 2010, he was invited to speak at the Ultimate Success Summit, an event held in Sydney, Australia. At this event, Secker shared the stage with such luminaries as Tony Robbins and Richard Branson, and even received a standing ovation from the audience for his riveting speech.